Search Results - "Davis, D.P"

Systemic associations of hidradenitis suppurativa by Kohorst, John J., MD, Kimball, Alexa B., MD, MPH, Davis, Mark D.P., MD

“…Hidradenitis suppurativa (HS) is a progressive, inflammatory disease that affects mostly young women and appears to be caused by inflammation of hair follicles…”
Get full text

Incidence of Leukocytoclastic Vasculitis, 1996 to 2010: A Population-Based Study in Olmsted County, Minnesota by Arora, Amrita, MD, Wetter, David A., MD, Gonzalez-Santiago, Tania M., MD, Davis, Mark D.P., MD, Lohse, Christine M., MS

“…Abstract Objective To determine the population-based incidence of leukocytoclastic vasculitis (LCV). Patients and Methods This is a retrospective…”
Get full text

A Population-Based Study of the Incidence of Burning Mouth Syndrome by Kohorst, John J., BA, Bruce, Alison J., MB, ChB, Torgerson, Rochelle R., MD, PhD, Schenck, Louis A., MS, Davis, Mark D.P., MD

“…Abstract Objective To calculate the incidence of burning mouth syndrome (BMS) in Olmsted County, Minnesota, from 2000 through 2010. Patients and Methods By…”
Get full text

Calciphylaxis: Natural history, risk factor analysis, and outcome by Weenig, Roger H., MD, Sewell, Lindsay D., MD, Davis, Mark D.P., MD, McCarthy, James T., MD, Pittelkow, Mark R., MD

“…Background Calciphylaxis is characterized by ischemic cutaneous ulceration, high mortality, and ineffective treatment. Methods We conducted a retrospective…”
Get full text

Sézary syndrome without erythroderma: A review of 16 cases at Mayo Clinic by Thompson, Agnieszka K., MD, Killian, Jill M., BS, Weaver, Amy L., MS, Pittelkow, Mark R., MD, Davis, Mark D.P., MD

“…Background Sézary syndrome (SS) is characterized by erythroderma with leukemic involvement. In atypical SS, leukemic involvement is present without…”
Get full text

Results of patch testing to a corticosteroid series: A retrospective review of 1188 patients during 6 years at Mayo Clinic by Davis, Mark D.P., MD, el-Azhary, Rokea A., MD, Farmer, Sara A., BA

“…Background Allergy to topical corticosteroids is more common than previously realized. To detect this allergy, a corticosteroid series is used for patch…”
Get full text

Blistering diseases: Clinical features, pathogenesis, treatment by Davis, Mark D.P., MD

Get full text

182: Evaluating the Impact of the 2003 San Diego Wildfires on Emergency Department Use by Kene, M.V, Jacoby, I.J, Davis, D.P, Killeen, J

Get full text

Survival, Risk Factors, and Effect of Treatment in 101 Patients With Calciphylaxis by McCarthy, James T., MD, el-Azhary, Rokea A., MD, PhD, Patzelt, Michelle T., MD, Weaver, Amy L., MS, Albright, Robert C., DO, Bridges, Alina D., DO, Claus, Paul L., MD, Davis, Mark D.P., MD, Dillon, John J., MD, El-Zoghby, Ziad M., MD, Hickson, LaTonya J., MD, Kumar, Rajiv, MD, McBane, Robert D., MD, McCarthy-Fruin, Kathleen A.M., BA, McEvoy, Marian T., MD, Pittelkow, Mark R., MD, Wetter, David A., MD, Williams, Amy W., MD

“…Abstract Objective To report on the survival and the associations of treatments upon survival of patients with calciphylaxis seen at a single center. Patients…”
Get full text

Squamous Cell Carcinoma in Perineal, Perianal, and Gluteal Hidradenitis Suppurativa: Experience in 12 Patients by Kohorst, John J, Shah, Kabeer K, Hallemeier, Christopher L, Baum, Christian L, Davis, Mark D.P

“…BACKGROUNDFew reports describe squamous cell carcinoma (SCC) arising in hidradenitis suppurativa (HS). OBJECTIVEThe 2 objectives were (1) to describe the…”
Get full text

Erythromelalgia: A Review of Medical Management Options and Our Approach to Management by Ma, Janice E., Lee, Jinnee U.J., Sartori-Valinotti, Julio C., Rooke, Thom W., Sandroni, Paola, Davis, Mark D.P.

“…Erythromelalgia (EM) is a rare disorder characterized by episodic, burning pain associated with erythema and warmth of the extremities. The feet and hands are…”
Get full text

Lupus-Like Syndrome Attributable to Anti—Tumor Necrosis Factor α Therapy in 14 Patients During an 8-Year Period at Mayo Clinic by Wetter, David A., MD, Davis, Mark D.P., MD

“…OBJECTIVE To examine clinical characteristics, laboratory features, and outcomes of patients with lupus-like syndrome attributable to anti—tumor necrosis…”
Get full text

Clinicopathologic correlation of hypocomplementemic and normocomplementemic urticarial vasculitis by DAVIS, M. D. P, DAOUD, M. S, KIRBY, B, GIBSON, L. E, ROGERS, R. S

“…Urticarial vasculitis is characterized by persistent urticarial lesions with histologic evidence of leukocytoclastic vasculitis. Hypocomplementemic urticarial…”
Get full text

Cutaneous manifestations of Churg-Strauss syndrome: A clinicopathologic correlation by Davis, Mark D.P., Daoud, Mazen S., McEvoy, Marian T., Daniel Su, W.P.

“…Background: Allergic granulomatosis of Churg-Strauss (Churg-Strauss syndrome) is a distinct clinical disease of multisystem vasculitis. Objective: We…”
Get full text

Recurrent erythema multiforme: Clinical characteristics, etiologic associations, and treatment in a series of 48 patients at Mayo Clinic, 2000 to 2007 by Wetter, David A., MD, Davis, Mark D.P., MD

“…Background Recurrent erythema multiforme (EM) is a condition of substantial morbidity. Our efforts toward the etiologic attribution and treatment of recurrent…”
Get full text

253: Description and Efficacy of Treatment of Hemodynamically Significant Bradycardia in a Large, Urban, Pacing-capable EMS System by Marsan, R.J, Vilke, G.M, Chan, T.C, Davis, D.P, Stepanski, B.M

Get full text

Severe Allergic Contact Dermatitis to Dermabond Prineo, a Topical Skin Adhesive of 2-Octyl Cyanoacrylate Increasingly Used in Surgeries to Close Wounds by Davis, Mark D P, Stuart, Michael J

Get more information

Patient Satisfaction and Quality of Life Following Surgery for Hidradenitis Suppurativa by Kohorst, John J, Baum, Christian L, Otley, Clark C, Roenigk, Randall K, Pemberton, John H, Dozois, Eric J, Tran, Nho V, Davis, Mark D.P

“…BACKGROUNDHidradenitis suppurativa (HS) is a progressive, recurrent inflammatory disorder. OBJECTIVETo assess long-term satisfaction and postoperative…”
Get full text

The resuscitation outcomes consortium (ROC) primed impedance threshold device (ITD) cardiac arrest trial: A prospective, randomised, double-blind, controlled clinical trial by Aufderheide, T.P, Nichol, G, Rea, T.D, Brown, S, Leroux, B.G, Pepe, P.E, Kudenchuk, P.J, Christenson, J, Daya, M.R, Dorian, P, Callaway, C.W, Idris, A.H, Andrusiek, D, Stephens, S.W, Hostler, D, Davis, D.P, Dunford, J.V, Pirrallo, R.G, Stiell, I.G, Clement, C.M, Craig, A, Van Ottingham, L, Schmidt, T.A, Wang, H.E, Weisfeldt, M.L, Ornato, J.P, Sopko, G

Get full text

Clinical features, causes, treatments, and outcomes of peristomal pyoderma gangrenosum (PPG) in 44 patients: The Mayo Clinic experience, 1996 through 2013 by Barbosa, Naiara S., MD, Tolkachjov, Stanislav N., MD, el-Azhary, Rokea A., MD, PhD, Davis, Mark D.P., MD, Camilleri, Michael J., MD, McEvoy, Marian T., MD, Bridges, Alina G., DO, Wetter, David A., MD

“…Background There are limited large case series of peristomal pyoderma gangrenosum (PPG), an uncommon cause of recalcitrant peristomal ulceration. Objective We…”
Get full text